Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli
Wenxin Keli (WXKL) is a traditional Chinese medicine drug approved for the treatment of cardiovascular diseases. This study aimed to identify WXKL-targeting genes involved in antiarrhythmic efficacy of WXKL. The Traditional Chinese Medicine Systems Pharmacology (TCMSP) technology platform was used t...
Saved in:
Main Authors: | Yusi Yao (Author), Yuhong Liu (Author), Zhihuan Zeng (Author), Yanqun Zhao (Author), Tudi Li (Author), Rong Chen (Author), Rendan Zhang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi-Wiley,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wenxin Keli for the Treatment of Arrhythmia-Systems Pharmacology and In Vivo Pharmacological Assessment
by: Xiaofeng Li, et al.
Published: (2021) -
Systematic review and meta-analysis of randomized controlled trials on Wenxin keli
by: Wang XY, et al.
Published: (2016) -
Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview
by: Guihua Tian, et al.
Published: (2018) -
Screening and Identification of Cardioprotective Compounds From Wenxin Keli by Activity Index Approach and in vivo Zebrafish Model
by: Hao Liu, et al.
Published: (2018) -
Xin Su Ning-A Review of Basic and Clinical Pharmacology Integrated With Traditional Chinese Medicine Antiarrhythmic Theory
by: Xuan Wang, et al.
Published: (2021)